Navigation Links
Larry Klayman files lawsuit against Former FDA commissioner Hamburg, Johnson & Johnson and others sued for alleged racketeering and other claims over dangerous drug Levaquin

WASHINGTON, Jan. 19, 2016 /PRNewswire/ -- Today, Larry Klayman, counsel for individual plaintiffs who were seriously harmed by the dangerous drug Levaquin, brought suit in the U.S. District Court for the District of Columbia alleging violations of the Racketeering and Corrupt Organizations Act ("RICO"), the Lanham Act, and a variety of common law torts. Filed Levaquin Complaint .pdf

According to Klayman, "Obama administration appointee, former FDA Commissioner Dr. Margaret Hamburg, is at the heart of this scandal, and her husband Peter Brown, co-CEO of Renaissance Technologies, L.L.C., a major New York hedge fund. While Dr. Hamburg was head of the FDA, her husband profited enormously from as much as half a billion dollars in Johnson & Johnson stock, the maker of Levaquin, held by Renaissance Technologies."

Levaquin is a drug intended to treat a range of infections, including routine sinus, skin and urinary tract infections.

The complaint alleges Dr. Hamburg and her husband and others at Renaissance Technologies, L.L.C., conspired with Johnson & Johnson and other defendants to suppress information about Levaquin's harmful effects. "To reveal it would have not only harmed Johnson & Johnson's profits, but invite significant lawsuits, driving Johnson & Johnson stock price downward, thereby financially harming Dr. Hamburg, her husband and Renaissance Technologies' profits. Plaintiffs were unwitting victims, suffering from a variety of medical conditions, some of which were just recently disclosed at an FDA Advisory Committee Hearing November 5, 2015.

The complaint can be found at and its allegations speak for themselves.

Klayman called it "a major scandal affecting the health plaintiffs and thousands of others. Defendants allegedly reaped large financial gains and profits at the expense of my clients. The entire sad episode exemplifies how some in private industry allegedly conspire and act with Washington D.C. public officials to greedily line their pockets, leaving everyone else to be damned."

"The complaint asks for millions of dollars in damages and justice," said Klayman, founder of Judicial Watch and Freedom Watch, and a former federal prosecutor who, during his tenure at the U.S. Department of Justice, not coincidentally prosecuted on behalf of the Food and Drug Administration and other federal agencies, as well as serving on the trial team that, in a landmark antitrust case, broke up the monopoly of AT&T.

For information, contact

Media contact: Adrienne Mazzone 561-750-9800 x2270;


SOURCE Larry Klayman
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors
2. Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors
3. MabVax Therapeutics Files IND for a Phase I Clinical Trial with 89Zr-HuMab-5B1
4. Medical Implants Market 10 Major Company Profiles and 2021 Forecasts
5. Lopez McHugh files Invokana Lawsuit Alleging Diabetic Ketoacidosis Injury
6. Relmada Therapeutics Files Federal Lawsuit Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern to Protect Interests of Relmada Stockholders
7. Spinal Fusion Market Forecast to 2020 With 13 Company Profiles
8. MabVax Therapeutics Files IND for Phase I Clinical Trial with HuMab 5B1 as a Therapeutic for Pancreatic Cancer
9. Global Molecular Diagnostics Market 2016: Emerging Technologies and Strategic Profiles of Leading Suppliers
10. Acute Lymphocytic/Lymphoblastic Leukemia Market: 4% CAGR Forecast to 2019, Company Profiles and More
11. Germany Hospital Coagulation Testing Market 2016 - Profiles of Major Current and Emerging Suppliers, Including their Sales and Market Shares
Post Your Comments:
(Date:7/17/2019)... ... July 17, 2019 , ... ... solution needed to attract new customers, better engage existing patients and collaborate with ... digital marketing services in tandem with an all-in-one platform. With the Updox approach, ...
(Date:7/17/2019)... ... 2019 , ... Triple W, an innovator of connected health ... will be highlighted at the Japan - U.S. Innovation Awards Symposium ... recognizes startups with Japanese founders developing exciting technologies and highly innovative business ideas ...
(Date:7/17/2019)... , ... July 17, 2019 , ... ... 11-13, in Phoenix, will provide strategies to keep pathologists, laboratory professionals and residents ... to improve outcomes and enhance patient care. , Renowned Speakers Covering Crucial ...
Breaking Medicine Technology:
(Date:7/17/2019)... HILLS, Calif. (PRWEB) , ... July 17, 2019 ... ... & toning device, the first that is capable of treating up to eight ... designed to perform total body muscle toning much faster and easier than previous muscle ...
(Date:7/17/2019)... ... July 17, 2019 , ... In order to achieve the mission, the design ... occur, from the accident scene, to the moment the teeth are replanted and fixed ... treatment. , They identified seven points, so called links in a chain, along this ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... participating in Medicare Advantage, Medicaid, and Marketplace programs is pleased to announce the ... Electronic Health Records (EHR) integration at the point of care to providers ...
(Date:7/17/2019)... BETHLEHEM, Pa. (PRWEB) , ... July 17, 2019 , ... ... (SLUHN) plastic surgeon Juan Carlos Martinez, MD, to relieve pressure on the nerves under ... Just after the Wescosville, PA woman turned 30 last year, her debilitating headaches began ...
(Date:7/17/2019)... ... 17, 2019 , ... Athena Software , a leading ... worldwide, has been awarded a California Multiple Award Schedules (CMAS) agreement by the ... and local government agencies in California by designating pre-approved suppliers from whom they ...
Breaking Medicine News(10 mins):